Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Responses of state Medicaid programs to buprenorphine diversion: doing more harm than good?

Literature DB >> 23877740

Responses of state Medicaid programs to buprenorphine diversion: doing more harm than good?

Robin E Clark¹, Jeffrey D Baxter.

Abstract

Entities: Chemical

Mesh：

Substances：
Buprenorphine

Year: 2013 PMID： 23877740 DOI： 10.1001/jamainternmed.2013.9059

Source DB: PubMed Journal: JAMA Intern Med ISSN： 2168-6106 Impact factor: 21.873

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

1. Overlapping buprenorphine, opioid, and benzodiazepine prescriptions among veterans dually enrolled in Department of Veterans Affairs and Medicare Part D.

Authors: Walid F Gellad; Xinhua Zhao; Carolyn T Thorpe; Joshua M Thorpe; Florentina E Sileanu; John P Cashy; Maria Mor; Jennifer A Hale; Thomas Radomski; Leslie R M Hausmann; Michael J Fine; Chester B Good
Journal: Subst Abus Date: 2016-12-07 Impact factor: 3.716

2. Risk Factors for Relapse and Higher Costs Among Medicaid Members with Opioid Dependence or Abuse: Opioid Agonists, Comorbidities, and Treatment History.

Authors: Robin E Clark; Jeffrey D Baxter; Gideon Aweh; Elizabeth O'Connell; William H Fisher; Bruce A Barton
Journal: J Subst Abuse Treat Date: 2015-05-07

3. Physicians as Mediators of Health Policy: Acceptance of Medicaid in the Context of Buprenorphine Treatment.

Authors: Hannah K Knudsen; Jamie L Studts
Journal: J Behav Health Serv Res Date: 2019-01 Impact factor: 1.505

4. Physicians' Decision-making When Implementing Buprenorphine With New Patients: Conjoint Analyses of Data From a Cohort of Current Prescribers.

Authors: Hannah K Knudsen; Michelle R Lofwall; Sharon L Walsh; Jennifer R Havens; Jamie L Studts
Journal: J Addict Med Date: 2018 Jan/Feb Impact factor: 3.702

5. Assessing Differences in the Availability of Opioid Addiction Therapy Options: Rural Versus Urban and American Indian Reservation Versus Nonreservation.

Authors: Katherine A Hirchak; Sean M Murphy
Journal: J Rural Health Date: 2016-03-14 Impact factor: 4.333

6. Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial.

Authors: David A Fiellin; Richard S Schottenfeld; Christopher J Cutter; Brent A Moore; Declan T Barry; Patrick G O'Connor
Journal: JAMA Intern Med Date: 2014-12 Impact factor: 21.873

Responses of state Medicaid programs to buprenorphine diversion: doing more harm than good?

1. Overlapping buprenorphine, opioid, and benzodiazepine prescriptions among veterans dually enrolled in Department of Veterans Affairs and Medicare Part D.

2. Risk Factors for Relapse and Higher Costs Among Medicaid Members with Opioid Dependence or Abuse: Opioid Agonists, Comorbidities, and Treatment History.

3. Physicians as Mediators of Health Policy: Acceptance of Medicaid in the Context of Buprenorphine Treatment.

4. Physicians' Decision-making When Implementing Buprenorphine With New Patients: Conjoint Analyses of Data From a Cohort of Current Prescribers.

5. Assessing Differences in the Availability of Opioid Addiction Therapy Options: Rural Versus Urban and American Indian Reservation Versus Nonreservation.

6. Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial.

Review 7. Buprenorphine Prescribing: To Expand or Not to Expand.

8. Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment.

9. Illicit buprenorphine use, interest in and access to buprenorphine treatment among syringe exchange participants.

10. Access to Addiction Pharmacotherapy in Private Health Plans.